… risk for sunitinib-induced toxicity. The aim of this study is to identify genetic markers in sunitinib
… that predispose for development of common sunitinib related toxicities: thrombocytopenia, …

… This study suggested that sunitinib could be effective in DTC. In a further study, the
efficacy of sunitinib on cell growth, signal transduction pathways, and thyroid-specific gene …

… and experimental study of sunitinib, we found that sunitinib can cause extensive renal …
sunitinib. Thus, our research will provide a theoretical basis for the future rational use of sunitinib …

… outcome in RCC with sunitinib and axitinib, small molecule VEGF receptor inhibitors, and …
the expected duration of sequential single agent efficacy is not achievable with current agents. …

… anti-cancer efficacy, as well as the pharmacokinetics of sunitinib and its active … sunitinib in
human ccRCC cell lines can be established in the laboratory environment to induce molecular …

… the VEGF-A gene have also been associated with efficacy for mRCC patients receiving
axitinib [7], whereas SNPs in the VEGFR3 gene have been associated with sunitinib efficacy [10]. …

… We primarily screened the anticancer efficacy of a broad range of sunitinib concentrations
against a panel of human cancer cell lines representative of diverse types; renal cell …

… In this study, we aimed to compare the efficacy of sunitinib … We reported that sorafenib
and sunitinib suppressed tumor … than that of 40 mg/kg sunitinib. Sorafenib inhibited p-eIF4E …

… the efficacy and safety of the tyrosine kinase inhibitor sunitinib … Sunitinib was administered
orally at a dose of 50 mg daily until … Conclusions: Sunitinib was efficacious in the treatment of …

… sunitinib, we identified interleukin 13 receptor alpha 2 (IL13RA2) as a candidate molecule
associated with the acquired sunitinib-… However, despite the efficacy of sunitinib, ccRCC often …